Edition:
United States

People: AstraZeneca PLC (AZN.L)

AZN.L on London Stock Exchange

5,099.00GBp
26 Sep 2016
Change (% chg)

-- (--)
Prev Close
5,099.00p
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,753,237
52-wk High
5,505.00p
52-wk Low
3,680.00p

Burlington, Bruce 

Dr. Bruce Burlington is Non-Executive Independent Director of AstraZeneca Plc. Bruce is a pharmaceutical product development and regulatory affairs consultant and brings experience in those areas to the Board. He is a pharmaceutical product development and regulatory affairs consultant and brings extensive experience in those areas. He spent 17 years with the FDA, serving as Director of its Center for Devices and Radiological Health as well as holding various senior roles in the Center for Drug Evaluation and Research. After leaving the FDA, he held various senior executive positions at Wyeth (now part of Pfizer). Other Appointments Bruce is a Non-Executive Director of the International Partnership for Microbicides, and a member of the scientific advisory boards of the International Medica Foundation and H. Lundbeck A/S.

Basic Compensation

Total Annual Compensation, GBP 105,000
Restricted Stock Awards, GBP --
Long-Term Incentive Plans, GBP --
All Other, GBP --
Fiscal Year Total, GBP 105,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --